|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
13.880 +0.040 (+0.289%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 3,414,217 | 4,217,571 | 3,937,815 | 2,579,774 |
| Net Cash from / (used in) Investing Activities | -- | (3,819,290) | (4,064,038) | (3,857,489) | (4,706,229) |
| Net Cash from / (used in) Financing Activities | -- | (1,336,250) | 4,428,475 | (819,408) | 1,467,129 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (1,741,323) | 4,582,008 | (739,082) | (659,326) |
| Cash & Cash Equivalents at beginning of period | -- | 11,170,067 | 6,459,717 | 7,333,511 | 8,284,371 |
| Effect of Foreign Exchange Rate Changes | -- | 73,645 | 128,342 | (134,712) | (300,164) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 9,502,389 | 11,170,067 | 6,459,717 | 7,324,881 |
| Remarks: | Real time quote last updated: 23/12/2024 10:40 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,224,799 |
| %Change | -31.332% |
| EPS / (LPS) | RMB 0.460 |
| NBV Per Share (¥) | RMB 17.561 |